✓ Medically reviewed✍️ HairBase editorial team📅 Last updated: June 14, 2026⏱ 1 min read
💡 Quick answer
Low-level laser therapy (LLLT) shines red light onto the scalp to stimulate follicles, and is commonly delivered through home devices shaped like combs, he
As an AliExpress affiliate, we may earn a commission from qualifying purchases.
Evidence B · Promising
Low-level laser therapy (LLLT) shines red light onto the scalp to stimulate follicles, and is commonly delivered through home devices shaped like combs, helmets, or caps. The proposed mechanism is that light energy stimulates follicle-cell activity to support growth. On the regulatory side, LLLT devices are FDA-cleared for safety — which means they can be used safely, not that efficacy is proven. The evidence tier is promising: some randomized trials have reported modest improvement.
However, studies differ widely in the device, wavelength, output, and exposure time used, so results vary considerably. In other words, even where benefit is reported, its size and consistency can depend heavily on the device and how it is used.
A realistic expectation is to view LLLT as a non-invasive add-on that complements proven treatments such as minoxidil and finasteride, rather than a standalone therapy. It has few side effects and is painless, making it an easy option to try, but it requires consistent use, and judging the effect takes several months.
Low-level laser therapy (LLLT) is one piece — build the whole plan
See how it ranks against every option, tuned to your stage, goal and budget.
1967Endre Mester (Hungary), using a low-power ruby laser (694 nm) on mice, serendipitously observed faster hair regrowth and wound healing at treated sites — the founding observation of 'laser biostimulation,' later termed photobiomodulation / low-level laser therapy.
2007The HairMax LaserComb (655 nm) received the first-ever FDA 510(k) clearance for an at-home LLLT device for male androgenetic alopecia (cleared as substantially equivalent to a predicate device, not via the drug-approval pathway).
2011FDA clearance of the HairMax LaserComb was expanded to include female pattern hair loss, broadening the cleared indication to both sexes.
2014Publication of the largest set of sham-controlled, double-blind RCTs of an LLLT comb device (Jimenez et al., Am J Clin Dermatol), establishing the core regulatory/clinical evidence base for the modality in both men and women.
2019First comprehensive systematic review and meta-analysis pooling LLLT-vs-sham RCTs for AGA (Liu et al., Lasers in Medical Science) confirmed a statistically significant increase in hair density but flagged substantial between-trial heterogeneity, framing the modern consensus that evidence is positive but low-to-moderate quality.
At 26 weeks, lasercomb-treated arms gained roughly +18 to +26 terminal hairs/cm2 versus only +1.6 to +9.4/cm2 in sham arms; differences were statistically significant (p<0.0001 for female 9- and 12-beam arms; male arms p=0.0017 to p=0.0249).
Active treatment increased hair counts by about 35% over sham in men (p=0.003) and about 37% over sham in women — pivotal trials supporting FDA clearance of helmet/cap-style LLLT devices.
Lasers in Surgery and Medicine
Liu et al., 2019 (systematic review & meta-analysis)2019
Meta-analysis of 8 studies comprising 11 double-blind RCTs of LLLT versus sham for androgenetic alopecia
LLLT significantly increased hair density versus sham, with a pooled standardized mean difference of 1.316 (95% CI 0.993-1.639); benefit was seen in both sexes and comb- and helmet-type devices, but the authors stressed the analysis was limited by heterogeneity of the included trials.
Lasers in Medical Science
Latest research: Recent work (2023-2026) has shifted from LLLT monotherapy toward combination regimens, with several 2024-2025 systematic reviews and meta-analyses reporting that LLLT plus topical minoxidil outperforms minoxidil alone with a comparable safety profile, while continuing to flag a limited, heterogeneous, and often industry-linked evidence base that calls for larger, standardized RCTs.
Summaries reflect published, peer-reviewed research and are not medical advice. See the linked sources for details.
LLLT devices are FDA-cleared for safety, which means they can be used safely, not that efficacy is proven. Some studies report modest improvement, but results vary widely with the device and how it's used. So it's more accurate to view it as an adjunct than a guaranteed treatment.
Can I just use the laser instead of medication?
LLLT is a low-risk, non-invasive option that's easy to try, but the size and consistency of its effect don't match proven medications. It's more realistic to use it alongside proven treatments like minoxidil or finasteride rather than on its own, and to plan your approach with a clinician.
How often should I use it?
Recommended session length and frequency differ by device, so follow the product guidance and your clinician's advice. In all cases, consistent use is needed to see any benefit, and judging the change takes several months. Stopping may make it hard to maintain results.
Not medical advice. General education only; it does not replace diagnosis or treatment by a licensed professional. Consult a board-certified dermatologist before starting, stopping or changing any treatment.